نتایج جستجو برای: platinum intermediate

تعداد نتایج: 152149  

Journal: :Molecular pharmacology 2004
Goli Samimi Kuniyuki Katano Alison K Holzer Roohangiz Safaei Stephen B Howell

The copper efflux transporters ATP7A and ATP7B sequester intracellular copper into the vesicular secretory pathway for export from the cell. The influence of these transporters on the pharmacodynamics of cisplatin, carboplatin, and oxaliplatin was investigated using human Menkes' disease fibroblasts (Me32a) that do not express either transporter and sublines molecularly engineered to express ei...

2011
S. B. Kaye N. Colombo B. J. Monk S. Tjulandin B. Kong M. Roy S. Chan E. Filipczyk-Cisarz H. Hagberg I. Vergote C. Lebedinsky T. Parekh P. Santabárbara Y. C. Park A. Nieto A. Poveda

BACKGROUND OVA-301 is a large randomized trial that showed superiority of trabectedin plus pegylated liposomal doxorubicin (PLD; CentoCor Ortho Biotech Products L.P., Raritan, NJ, USA). over single-agent PLD in 672 patients with relapsed ovarian cancer, particularly in the partially platinum-sensitive subgroup [platinum-free interval (PFI) of 6-12 months]. This superiority has been suggested to...

Journal: :Bioinformatics 2009
Timothy V. Pyrkov Anton O. Chugunov Nikolay A. Krylov Dmitry E. Nolde Roman G. Efremov

UNLABELLED The PLATINUM (Protein-Ligand ATtractions Investigation NUMerically) web service is designed for analysis and visualization of hydrophobic/hydrophilic properties of biomolecules supplied as 3D-structures. Furthermore, PLATINUM provides a number of tools for quantitative characterization of the hydrophobic/hydrophilic match in biomolecular complexes e.g. in docking poses. These complem...

Journal: :Cancer research 2011
Euan A Stronach Albandri Alfraidi Nona Rama Christoph Datler James B Studd Roshan Agarwal Tankut G Guney Charlie Gourley Bryan T Hennessy Gordon B Mills Antonello Mai Robert Brown Roberto Dina Hani Gabra

Ovarian cancer frequently acquires resistance to platinum chemotherapy, representing a major challenge for improving patient survival. Recent work suggests that resistant clones exist within a larger drug-sensitive cell population prior to chemotherapy, implying that resistance is selected for rather than generated by treatment. We sought to compare clinically derived, intrapatient paired model...

2017
Man Xiao Zaiju Huang Jing Cai Jinghui Jia Yuzeng Zhang Weihong Dong Zehua Wang

BACKGROUND Platinum-based agents are widely used in chemotherapy against solid tumors and insufficient intracellular drug accumulation is one of the leading causes of platinum resistance which is associated with poor survival of tumor patients. Thus, the detection of intracellular platinum is pivotal for studies aiming to overcome platinum resistance. In the present study, we aimed to establish...

2015
Dimitra T. Stefanou Aristotelis Bamias Hara Episkopou Soterios A. Kyrtopoulos Maria Likka Theodore Kalampokas Stylianos Photiou Nikos Gavalas Petros P. Sfikakis Meletios A. Dimopoulos Vassilis L. Souliotis

Ovarian carcinoma (OC) is the most lethal gynecological malignancy. Despite the advances in the treatment of OC with combinatorial regimens, including surgery and platinum-based chemotherapy, patients generally exhibit poor prognosis due to high chemotherapy resistance. Herein, we tested the hypothesis that DNA damage response (DDR) pathways are involved in resistance of OC patients to platinum...

2017
Koji Matsuo Muneaki Shimada Harushige Yokota Toyomi Satoh Hidetaka Katabuchi Shoji Kodama Hiroshi Sasaki Noriomi Matsumura Mikio Mikami Toru Sugiyama

Objective To examine the effectiveness of systemic chemotherapy following radical hysterectomy for women with intermediate-risk stage IB cervical cancer. Materials and Methods This is a retrospective analysis of a previously organized nation-wide cohort study examining 6,003 women with stage IB-IIB cervical cancer who underwent radical hysterectomy between 2004 and 2008 in Japan. Survival of ...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2016
Erica Hlavin Bell Arup R Chakraborty Xiaokui Mo Ziyan Liu Konstantin Shilo Simon Kirste Petra Stegmaier Maureen McNulty Niki Karachaliou Rafael Rosell Gerold Bepler David P Carbone Arnab Chakravarti

PURPOSE Identification of predictive biomarkers is critically needed to improve selection of patients who derive the most benefit from platinum-based chemotherapy. We hypothesized that decreased expression of SMARCA4/BRG1, a known regulator of transcription and DNA repair, is a novel predictive biomarker of increased sensitivity to adjuvant platinum-based therapies in non-small cell lung cancer...

2010
Robert L. Brainard

The thermal decomposition of trans-chloroethylbis(triethylphosphine)platinum(II) (L2PtEtCl, 1) in cyclohexane solution at 158 oC yields trons-chlorohydridobis(triethylphosphine)platinum(II) (3) and ethylene. The most probable rate-limiting step for this reaction is dissociation of ethylene from a five-coordinate l8-electron plat inum(Il) intermediate, L2PtHCl(CzH) Q). Three pathways might be in...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید